{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:05:39Z","timestamp":1781787939943,"version":"3.54.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,24]]},"abstract":"<jats:p>Bladder cancer (BC) is a malignant tumor that occurs in bladder mucosa. However, relationship between myosin light chain kinase (MYLK) and CALD1 and BC remains unclear. The BC datasets GSE65635 and GSE100926 were downloaded from gene expression omnibus by GPL14951 and GPL14550. Multiple datasets were merged and batched. Differentially expressed genes (DEGs) were screened and weighted gene co-expression network analysis was performed. gene ontology (GO) and Kyoto Encyclopedia of Gene and Genome analysis, gene set enrichment analysis, immune infiltration analysis, survival analysis and Comparative Toxicogenomics Database were performed. TargetScan screened miRNAs that regulated central DEGs. 1026 DEGs were identified. According to GO analysis, DEGs were mainly enriched in cancer pathway, cGMP-PKG signaling pathway, Apelin signaling pathway and proteoglycans in cancer. The enrichment items are similar to GO and Kyoto Encyclopedia of Gene and Genome enrichment projects for DEGs, which were mainly enriched in cancer pathways and leukocyte trans-endothelial cell migration. Among enrichment projects of metascape, GO has regulation of the enzyme-linked receptor protein signaling pathway and silk-based process, as well as an enrichment network stained by enrichment terms and <jats:italic toggle=\"yes\">P<\/jats:italic> values. Nine core genes (ACTA2, MYLK, MYH11, MYL9, ACTG2, TPM1, TPM2, TAGLN and CALD1) were obtained, which were highly expressed in tumor tissue samples and lowly expressed in normal tissue samples. Nine genes were associated with necrosis, inflammation, tumor, edema, and ureteral obstruction. MYLK and CALD1 are highly expressed in the BC. The higher expression of MYLK and CALD1, the worse prognosis.<\/jats:p>","DOI":"10.1097\/md.0000000000036302","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:06:49Z","timestamp":1701716809000},"page":"e36302","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["MYLK and CALD1 as molecular targets in bladder cancer"],"prefix":"10.1097","volume":"102","author":[{"given":"Hui","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[{"name":"Research Center, Hebei Province Hospital of Chinese Medicine, Affiliated Hospital of Hebei University of Traditional Chinese Medicine, Shijiazhuang, Hebei, China. Department of Pathology and Laboratory Medicine, Department of Pathology, Kanazawa Medical University, Uchinada, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of anesthesiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liman","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of ophthalmology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosen","family":"Song","sequence":"additional","affiliation":[{"name":"Department of urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9938-6415","authenticated-orcid":false,"given":"Tingting","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"1024739","DOI":"10.3389\/fonc.2022.1024739","article-title":"Robotic-assisted versus standard laparoscopic radical cystectomy in bladder cancer: a systematic review and meta-analysis.","volume":"12","author":"Long","year":"2022","journal-title":"Front Oncol"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ncrna.2022.12.002","article-title":"lncRNA-mediated ceRNA network in bladder cancer.","volume":"8","author":"Li","year":"2023","journal-title":"Noncoding RNA Res"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer.","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ijc.34228","article-title":"The causal association between smoking, alcohol consumption and risk of bladder cancer: a univariable and multivariable Mendelian randomization study.","volume":"151","author":"Xiong","year":"2022","journal-title":"Int J Cancer"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/JU.0000000000002449","article-title":"Association of biochemically verified post-diagnosis smoking and nonmuscle-invasive bladder cancer recurrence risk.","volume":"207","author":"Furberg","year":"2022","journal-title":"J Urol"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NPR.0000512251.61454.5c","article-title":"Bladder cancer: risk factors, diagnosis, and management.","volume":"42","author":"Farling","year":"2017","journal-title":"Nurse Pract"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes.","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"20902","DOI":"10.1038\/s41598-022-24511-z","article-title":"Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours.","volume":"12","author":"Goh","year":"2022","journal-title":"Sci Rep"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-019-1515-3","article-title":"CADM1 is a TWIST1-regulated suppressor of invasion and survival.","volume":"10","author":"Hartsough","year":"2019","journal-title":"Cell Death Dis"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"e32825","DOI":"10.1097\/MD.0000000000032825","article-title":"CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/s1677-5538.ibju.2020.99.01","article-title":"Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.","volume":"46","author":"Hamad","year":"2020","journal-title":"Int Braz J Urol"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"9170274","DOI":"10.1155\/2022\/9170274","article-title":"Three-dimensional ultrasound images in the assessment of bladder tumor health monitoring under deep learning algorithms.","volume":"2022","author":"Shao","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-020-01739-z","article-title":"LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p\/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.","volume":"39","author":"Teng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1080\/21655979.2021.1944019","article-title":"LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer.","volume":"12","author":"Luo","year":"2021","journal-title":"Bioengineered"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41436-018-0038-0","article-title":"MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.","volume":"21","author":"Wallace","year":"2019","journal-title":"Genet Med"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","article-title":"Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway.","volume":"403","author":"Zhong","year":"2017","journal-title":"Cancer Lett"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/ddr.21835","article-title":"CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a.","volume":"82","author":"Ye","year":"2021","journal-title":"Drug Dev Res"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"779","DOI":"10.56434\/j.arch.esp.urol.20227509.114","article-title":"Identification of hub genes associated with progression and prognosis of bladder cancer by integrated bioinformatics analysis.","volume":"75","author":"Jiang","year":"2022","journal-title":"Arch Esp Urol"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/genes12030378","article-title":"MYLK and PTGS1 genetic variations associated with osteoporosis and benign breast tumors in Korean women.","volume":"12","author":"Cho","year":"2021","journal-title":"Genes (Basel)"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/carcin\/bgt409","article-title":"Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.","volume":"35","author":"Lim","year":"2014","journal-title":"Carcinogenesis"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.78.9.5652","article-title":"Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin.","volume":"78","author":"Sobue","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1074\/mcp.M700590-MCP200","article-title":"Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.","volume":"7","author":"Thorsen","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0002-9440(10)63778-9","article-title":"Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature.","volume":"164","author":"Zheng","year":"2004","journal-title":"Am J Pathol"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.21037\/atm-21-4192","article-title":"CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK\/STAT signaling pathway.","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"40370","DOI":"10.18632\/oncotarget.5458","article-title":"Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"R28-20250524","doi-asserted-by":"crossref","first-page":"e13847","DOI":"10.1097\/MD.0000000000013847","article-title":"CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltim)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:02:13Z","timestamp":1748109733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":28,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036302","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}